We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$112M
AUM Growth
+$2.51M
Cap. Flow
-$831K
Cap. Flow %
-0.74%
Top 10 Hldgs %
18.4%
Holding
164
New
24
Increased
48
Reduced
65
Closed
13

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$1.15M
2
BAX icon
Baxter International
BAX
+$952K
3
NTRS icon
Northern Trust
NTRS
+$934K
4
TGT icon
Target
TGT
+$806K
5
SPXC icon
SPX Corp
SPXC
+$711K

Sector Composition

Rank Sector Weight
1 Industrials 23.8%
2 Healthcare 16.26%
3 Energy 13.01%
4 Financials 11.23%
5 Consumer Staples 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
76
Zoetis
ZTS
$32.4B
$630K 0.56%
19,525
+950
+5% +$29.1K
DEO icon
77
Diageo
DEO
$51.6B
$624K 0.56%
4,900
+300
+7% +$37.8K
NE
78
DELISTED
Noble Corporation
NE
$618K 0.55%
21,050
+10,411
+98% +$286K
BA icon
79
Boeing
BA
$184B
$604K 0.54%
4,750
+1,050
+28% +$137K
JWN
80
DELISTED
Nordstrom
JWN
$601K 0.54%
8,854
-3,221
-27% -$209K
DRI icon
81
Darden Restaurants
DRI
$24.1B
$596K 0.53%
+14,403
New +$638K
BMY icon
82
Bristol-Myers Squibb
BMY
$131B
$592K 0.53%
+12,200
New +$601K
HOS
83
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$592K 0.53%
12,625
-7,700
-38% -$327K
SU icon
84
Suncor Energy
SU
$71.8B
$584K 0.52%
13,700
-1,000
-7% -$39K
SRCL
85
DELISTED
Stericycle Inc
SRCL
$580K 0.52%
4,900
+600
+14% +$68.7K
SWN
86
DELISTED
Southwestern Energy Company
SWN
$567K 0.51%
+12,475
New +$578K
COF icon
87
Capital One
COF
$135B
$562K 0.5%
6,800
-3,400
-33% -$264K
RKT
88
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$549K 0.49%
10,400
TROW icon
89
T. Rowe Price
TROW
$24.2B
$519K 0.46%
6,150
-100
-2% -$8.16K
ABBV icon
90
AbbVie
ABBV
$431B
$517K 0.46%
9,158
-5,400
-37% -$283K
CBI
91
DELISTED
Chicago Bridge & Iron Nv
CBI
$515K 0.46%
7,550
+3,650
+94% +$290K
CLX icon
92
Clorox
CLX
$12.8B
$507K 0.45%
5,550
+1,350
+32% +$121K
ANSS
93
DELISTED
Ansys
ANSS
$497K 0.45%
6,550
-1,075
-14% -$80.6K
HSP
94
DELISTED
HOSPIRA INC
HSP
$493K 0.44%
9,600
-5,700
-37% -$271K
CMI icon
95
Cummins
CMI
$88.7B
$490K 0.44%
3,175
-1,225
-28% -$185K
NSC icon
96
Norfolk Southern
NSC
$76.9B
$489K 0.44%
4,750
-6,200
-57% -$608K
NTRS icon
97
Northern Trust
NTRS
$33.7B
$482K 0.43%
7,500
-15,150
-67% -$934K
VRSK icon
98
Verisk Analytics
VRSK
$24.7B
$482K 0.43%
8,025
+1,375
+21% +$82.2K
VZ icon
99
Verizon
VZ
$195B
$480K 0.43%
9,809
+350
+4% +$17K
ROC
100
DELISTED
ROCKWOOD HLDGS INC
ROC
$464K 0.42%
6,100
-100
-2% -$7.35K

Similar funds

New England Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, New England Research & Management held 164 positions worth $112M, up 2.3% from $109M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

New England Research & Management's Q2 2014 filing shows 24 new, 48 increased, 65 reduced and 13 closed positions. Its largest new stake was Dorman Products: 16,950 shares worth $836K. The largest sale was Freeport-McMoran, an estimated $1.15M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • New England Research & Management's largest Q2 2014 buy was Dorman Products: 16,950 shares worth $836K.
  • New England Research & Management added most to Procter & Gamble in Q2 2014, an estimated $778K increase.
  • New England Research & Management's biggest Q2 2014 reduction was Baxter International, cutting an estimated $952K.
  • New England Research & Management fully exited Freeport-McMoran in Q2 2014, selling an estimated $1.15M.
  • New England Research & Management's ten largest holdings make up 18% of its $112M portfolio in Q2 2014.
  • New England Research & Management opened 24 new positions and closed 13 in Q2 2014.
  • New England Research & Management's portfolio value rose 2.3% quarter-over-quarter to $112M.

Based on New England Research & Management's 13F filing for Q2 2014, filed 1 Jul 2014.